News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
-
05 11 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $550 million aggregate principal...
-
05 08 2020 1,000 COVID-19 test kits will be distributed each week to Federally Qualified Health Centers in GeorgiaATLANTA, GA – Peach State Health announced today a collaboration with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, to increase access to...
-
05 05 2020 Quest Diagnostics Incorporated (NYSE: DGX) today announced that its 2020 Annual Meeting of Stockholders (the "Annual Meeting") will now be held solely by remote communication through a live,...
-
04 29 2020 Company to join forces with Quest Diagnostics to expand access to COVID-19 testing at critical safety net providers across the countryCentene (NYSE: CNC) announced today a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase access to real-time reverse...
04 28 2020 Provides physician-guided insight into COVID-19 immune response without a visit to the doctorBeginning today, individuals can purchase COVID-19 antibody testing for themselves online, without visiting a doctor's office, through QuestDirect, the consumer-initiated testing business of Quest...
-
04 22 2020 - First quarter revenues of $1.82 billion, down 3.7% from 2019Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2020. "We were...
04 21 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood...
-
04 09 2020 CareDx Collaborates with ExamOne, a Quest Diagnostics Company, to Expand Mobile Phlebotomy Coverage Across the United States for Transplant Patients who are High Risk for COVID-19SOUTH SAN FRANCISCO, Calif., April 09, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically...
-
04 07 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2020 results on Wednesday, April 22, 2020,...
-
03 21 2020 Individuals Who are 60 Years or Older or Who Have Other High-Risk Factors for Adverse COVID-19 Outcomes to Receive VIP Access During First Hour of Each DayThrough its "Peace of Mind" program, Quest Diagnostics (NYSE: DGX) is taking extra measures to ensure individuals who are the most vulnerable to adverse COVID-19 outcomes have special VIP-level...